The insomnia market size is valued at USD 5.6 Bn in 2026.
The insomnia market is projected to grow at a CAGR of 7% by 2033.
The insomnia market growth drivers include rising work stress, increasing sleep disorders, and growing depression cases.
North America is a dominating region for insomnia market.
Eisai Co., Ltd., Idorsia Ltd., Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Pfizer Inc. are some leading industry players in the insomnia market.